These results are consistent with studies showing that DLL1 downregulation impairs tumor growth and tumor cell proliferation in xenografts [17] and MCF-7 proliferation and apoptosis [18], suggesting that decreased proliferation and induction of apoptosis accounted, at least partially, for the Dl1.72 anti-tumor effects. This evidence concerns the gene DLL1 and neoplasm.